Related Experiment Videos
Peripheral neuropathy caused by proteolipid protein gene mutations
J Y Garbern1, F Cambi, R Lewis
1Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. j_garbern@wayne.edu
Annals of the New York Academy of Sciences
|December 10, 1999
Summary
Null mutations in the proteolipid protein (PLP) gene cause peripheral neuropathy in Pelizaeus-Merzbacher disease (PMD). The DM20 protein alone is sufficient for normal peripheral nerve function.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Pelizaeus-Merzbacher disease (PMD) is a central nervous system dysmyelinating disorder.
- It is typically caused by mutations in the proteolipid protein (PLP) gene.
- Peripheral nerve function is generally considered normal in PMD patients.
Purpose of the Study:
- To investigate the role of PLP gene mutations in peripheral nerve function.
- To determine if specific mutations or splice variants affect peripheral nerves.
- To understand the differential roles of PLP and DM20 in the central and peripheral nervous systems.
Main Methods:
- Analysis of patients with various PLP gene mutations (null, duplications, missense, nonsense).
- Assessment of peripheral nerve function and structure in affected individuals.
- Correlation of specific mutation types with clinical presentation and nerve status.
Main Results:
- Null mutations in the PLP gene lead to demyelinating peripheral neuropathy.
- Duplications and a specific missense mutation (Pro14 to Leu) do not impair peripheral nerve function.
- A nonsense mutation affecting only PLP but not DM20 results in a mild syndrome with normal peripheral nerve function.
Conclusions:
- The alternatively spliced DM20 protein is sufficient to maintain normal peripheral nerve function.
- Different domains of PLP/DM20 may have distinct roles in the central versus peripheral nervous systems.
- Understanding genotype-phenotype correlations is crucial for PMD diagnosis and management.